Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data
| Image |  |
|---|---|
| Description | scholarly article by Artur César Fassoni et al published November 2018 in Haematologica |
| Author/s |
author: Artur César Fassoni |
| Publication date | November 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |